KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Enterprise Value (2016 - 2025)

Moderna (MRNA) has disclosed Enterprise Value for 10 consecutive years, with -$5.8 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 17.45% to -$5.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.8 billion through Dec 2025, up 17.45% year-over-year, with the annual reading at -$5.8 billion for FY2025, 17.45% up from the prior year.
  • Enterprise Value for Q4 2025 was -$5.8 billion at Moderna, down from -$4.5 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$4.5 billion in Q3 2025, with the low at -$10.7 billion in Q4 2021.
  • Average Enterprise Value over 5 years is -$7.9 billion, with a median of -$8.2 billion recorded in 2021.
  • The sharpest move saw Enterprise Value crashed 535.07% in 2021, then soared 39.55% in 2025.
  • Over 5 years, Enterprise Value stood at -$10.7 billion in 2021, then rose by 7.69% to -$9.9 billion in 2022, then rose by 13.11% to -$8.6 billion in 2023, then rose by 18.35% to -$7.0 billion in 2024, then grew by 17.45% to -$5.8 billion in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$5.8 billion, -$4.5 billion, and -$5.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.